Cargando…

Metabolic Plasticity in Ovarian Cancer Stem Cells

Ovarian Cancer is the fifth most common cancer in females and remains the most lethal gynecological malignancy as most patients are diagnosed at late stages of the disease. Despite initial responses to therapy, recurrence of chemo-resistant disease is common. The presence of residual cancer stem cel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ghoneum, Alia, Gonzalez, Daniela, Abdulfattah, Ammar Yasser, Said, Neveen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7281273/ https://www.ncbi.nlm.nih.gov/pubmed/32429566 http://dx.doi.org/10.3390/cancers12051267

Ejemplares similares

Targeting the PI3K/AKT/mTOR/NFκB Axis in Ovarian Cancer
por: Ghoneum, Alia, et al.
Publicado: (2020)

Redox Homeostasis and Metabolism in Cancer: A Complex Mechanism and Potential Targeted Therapeutics
por: Ghoneum, Alia, et al.
Publicado: (2020)

SPARC Inhibits Metabolic Plasticity in Ovarian Cancer
por: Naczki, Christine, et al.
Publicado: (2018)

PI3K-AKT-mTOR and NFκB Pathways in Ovarian Cancer: Implications for Targeted Therapeutics
por: Ghoneum, Alia, et al.
Publicado: (2019)

Metabolomic credentialing of murine carcinogen-induced urothelial cancer
por: Afify, Hesham, et al.
Publicado: (2021)

Role of tumor microenvironment in ovarian cancer pathobiology
por: Ghoneum, Alia, et al.
Publicado: (2018)

Role of tumor microenvironment in the pathobiology of ovarian cancer: Insights and therapeutic opportunities
por: Ghoneum, Alia, et al.
Publicado: (2018)

Regulation of the bi-directional cross-talk between ovarian cancer cells and adipocytes by SPARC
por: John, Bincy, et al.
Publicado: (2019)

Compound C Inhibits Ovarian Cancer Progression via PI3K-AKT-mTOR-NFκB Pathway
por: Ghoneum, Alia, et al.
Publicado: (2022)

Chemokines and cellular plasticity of ovarian cancer stem cells
por: Zou, Weiping, et al.
Publicado: (2015)

Metabolic plasticity of cancer stem cells
por: Luo, Ming, et al.
Publicado: (2015)

Metabolic Plasticity of Stem Cells and Macrophages in Cancer
por: Krstic, Jelena, et al.
Publicado: (2017)

Nano-hole induction by nanodiamond and nanoplatinum liquid, DPV576, reverses multidrug resistance in human myeloid leukemia (HL60/AR)
por: Ghoneum, Alia, et al.
Publicado: (2013)

Metabolic Plasticity of Cancer Stem Cells in Response to Microenvironmental Cues
por: Xie, Yunong, et al.
Publicado: (2022)

Chemoresistance in ovarian cancer: exploiting cancer stem cell metabolism
por: Li, Shan-Shan, et al.
Publicado: (2018)

Regulation of Metabolic Plasticity in Cancer Stem Cells and Implications in Cancer Therapy
por: Papadaki, Styliani, et al.
Publicado: (2022)

Ovarian cancer plasticity and epigenomics in the acquisition of a stem-like phenotype
por: Berry, Nicholas B, et al.
Publicado: (2008)

Distinct metabolic responses of an ovarian cancer stem cell line
por: Vermeersch, Kathleen A, et al.
Publicado: (2014)

Recent advances in understanding the metabolic plasticity of ovarian cancer: A systematic review
por: Kobayashi, Hiroshi
Publicado: (2022)

ISG15 and ISGylation is required for pancreatic cancer stem cell mitophagy and metabolic plasticity
por: Alcalá, Sonia, et al.
Publicado: (2020)

Different pancreatic cancer microenvironments convert iPSCs into cancer stem cells exhibiting distinct plasticity with altered gene expression of metabolic pathways
por: Hassan, Ghmkin, et al.
Publicado: (2022)

Unveiling Metabolic Vulnerability and Plasticity of Human Osteosarcoma Stem and Differentiated Cells to Improve Cancer Therapy
por: Della Sala, Gerardo, et al.
Publicado: (2021)

Selective induction of apoptosis in human gastric cancer cells by Lactobacillus kefiri (PFT), a novel kefir product
por: GHONEUM, MAMDOOH, et al.
Publicado: (2015)

The Metabolic Inhibitor CPI-613 Negates Treatment Enrichment of Ovarian Cancer Stem Cells
por: Bellio, Chiara, et al.
Publicado: (2019)

RhoGDI2 suppresses bladder cancer metastasis via reduction of inflammation in the tumor microenvironment
por: Said, Neveen, et al.
Publicado: (2012)

Cancer stem cells, plasticity, and drug resistance
por: Lionetti, Maria Chiara, et al.
Publicado: (2020)

Metabolic heterogeneity underlies reciprocal fates of T(H)17 cell stemness and plasticity
por: Karmaus, Peer W F, et al.
Publicado: (2018)

Ovarian Epithelial Cancer Stem Cells
por: Conic, Irena, et al.
Publicado: (2011)

Cancer Stem Cells and Epithelial Ovarian Cancer
por: Dyall, Sheetal, et al.
Publicado: (2010)

Epigenetics and metabolism at the crossroads of stress-induced plasticity, stemness and therapeutic resistance in cancer
por: Ravindran Menon, Dinoop, et al.
Publicado: (2020)

Insights from animal models of bladder cancer: recent advances, challenges, and opportunities
por: John, Bincy Anu, et al.
Publicado: (2017)

The Therapeutic Implications of Plasticity of the Cancer Stem Cell Phenotype
por: Leder, Kevin, et al.
Publicado: (2010)

Cancer Stem Cells: Plasticity Works against Therapy
por: Vinogradova, T. V., et al.
Publicado: (2015)

Metformin against Cancer Stem Cells through the Modulation of Energy Metabolism: Special Considerations on Ovarian Cancer
por: Kim, Tae Hun, et al.
Publicado: (2014)

Roles of SPARC in urothelial carcinogenesis, progression and metastasis
por: Said, Neveen
Publicado: (2016)

Architectural control of metabolic plasticity in epithelial cancer cells
por: Al-Masri, Maia, et al.
Publicado: (2021)

The Flick of a Switch: Conferring Survival Advantage to Breast Cancer Stem Cells Through Metabolic Plasticity
por: Walsh, Hayley R., et al.
Publicado: (2019)

Genomic and transcriptomic plasticity in treatment-naïve ovarian cancer
por: Hoogstraat, Marlous, et al.
Publicado: (2014)

Editorial: Metabolic Plasticity of Cancer
por: Rodríguez-Enríquez, Sara, et al.
Publicado: (2020)

Metabolism and microenvironment in cancer plasticity
por: Baldini, Nicola, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_8eap9pjpf7k4aktem4ggikboqj